Equities

Shanghai Henlius Biotech Inc

Shanghai Henlius Biotech Inc

Actions
  • Price (HKD)23.05
  • Today's Change-0.10 / -0.43%
  • Shares traded213.60k
  • 1 Year change+100.09%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income570(694)(957)
Depreciation/depletion209178134
Non-Cash items161299336
Cash taxes paid, supplemental211.370
Cash interest paid, supplemental13011583
Changes in working capital(42)1,099511
Total cash from operations1,04898290
INVESTING
Capital expenditures(1011)(1365)(1131)
Other investing and cash flow items, total7.016.56(550)
Total cash from investing(1004)(1359)(1681)
FINANCING
Financing cash flow items(130)(115)(83)
Total cash dividends paid------
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net274973732
Total cash from financing144858648
NET CHANGE IN CASH
Foreign exchange effects6.2738(17)
Net change in cash194518(959)
Net cash-begin balance/reserved for future use6731551,114
Net cash-end balance/reserved for future use868673155
SUPPLEMENTAL INCOME
Depreciation, supplemental209178134
Cash interest paid, supplemental13011583
Cash taxes paid, supplemental211.370
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.